ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
Article in Frontiers in Oncology (January 2024)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (January 2024)
Article in Translational Lung Cancer Research (December 2023)
Article in Frontiers in Oncology (October 2023)